The U.S. Food and Drug Administration (FDA) classified a popular energy beverage sold nationally online with one of its three risk levels.
“The recall is due to a misprint on the label that incorrectly identifies the total caffeine content on the can,” FDA officials said. “The item contains 300mg of caffeine, instead of 150mg as provided on the can.”
Company leaders did not respond to requests for comment by the time of publication.
The 16-ounce aluminum cans are sold in a 12-pack with UPC 850075595655.
Ed McCormick, a food science consultant and founder of Cape Crystal Brands, said mislabeling is often discovered through routine testing usually conducted by regulators, a third-party laboratory, or a competitor’s analysis.
“These discrepancies usually come to light when someone verifies whether the product actually matches its label claims,” McCormick told NTD.
The recall was originally announced on Dec. 2, 2025.
Since then, the FDA flagged the withdrawn product with a Level 3 risk alert.
A Class 3 event involves products that violate regulations but are unlikely to cause health problems, such as minor labeling errors.
A Class 1 event is defined on the FDA website as having a reasonable probability that the use of or exposure to will cause serious adverse health consequences or death, while Class 2 signals that the risk is temporary or adverse health consequences are medically reversible.
Company leaders did not respond to requests for comment.
“The FDA does not test these products before the consumer takes them, so problems with the label only come to light after the product has been on the market for an extended time,” Wagner Reese managing partner and attorney Stephen Wagner told NTD. “Unfortunately, that's the way the world really is, and people should realize that no one is checking these products.”
The 24,960 withdrawn collagen dietary supplements were sold nationwide on Amazon until the potential for manganese underlabeling was identified.
“The firm initiated a voluntary recall after [National Sanitation Foundation] NSF testing showed that labeled ingredient quantities did not align with analytical test results,” FDA officials said. “Manganese level was below label quantity.”